The clinical management of COPD exacerbations: an update

TN Bonten, MJ Kasteleyn, C Taube… - Expert Review of …, 2016 - Taylor & Francis
Clinical management of chronic obstructive pulmonary disease (COPD) exacerbations is of
high importance because exacerbations reduce quality of life, increase mortality and carry …

Exacerbations of COPD

ID Pavord, PW Jones, PR Burgel… - International journal of …, 2016 - Taylor & Francis
Exacerbations of chronic obstructive pulmonary disease (COPD) are defined as sustained
worsening of a patient's condition beyond normal day-to-day variations that is acute in onset …

Association between incidence of acute exacerbation and medication therapy in patients with COPD

DC Suh, H Lau, HO La, I Choi… - Current medical research …, 2010 - Taylor & Francis
Background: As exacerbations of chronic obstructive pulmonary disease (COPD)
significantly worsen patients' health status and increase disease-related mortality, greater …

Determinants of exacerbation risk in patients with COPD in the TIOSPIR study

PMA Calverley, K Tetzlaff, D Dusser… - … journal of chronic …, 2017 - Taylor & Francis
Background Exacerbation history is used to grade the risk of COPD exacerbation, but its
reliability and relationship to other risk factors and prior therapy is unclear. To examine these …

Treatment of COPD exacerbations: pharmacologic options and modification of risk factors

AR Blanchard - Postgraduate medicine, 2002 - Taylor & Francis
PREVIEW Acute exacerbations of chronic obstructive pulmonary disease (COPD) pose a
continuing threat to quality and length of life in affected patients. As the prevalence of the …

COPD: early diagnosis and treatment to slow disease progression

T Welte, C Vogelmeier, A Papi - International journal of clinical …, 2015 - Wiley Online Library
Aims Chronic obstructive pulmonary disease (COPD) is usually a progressive condition.
Undiagnosed early‐stage disease, particularly in symptomatic patients, is likely to become …

Bringing stability to the chronic obstructive pulmonary disease patient: clinical and pharmacological considerations for frequent exacerbators

S Gulati, JM Wells - Drugs, 2017 - Springer
Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are critical events
associated with an accelerated loss of lung function, increased morbidity, and excess …

Managing exacerbations of COPD: how much progress have we made?

F Baraldi, M Barrecheguren, A Papi… - COPD in the 21st …, 2024 - books.google.com
The pharmacological treatment of exacerbations of COPD has not significantly changed in
the last decades. The use of short-acting bronchodilators to improve symptoms, systemic …

Use of inhaled corticosteroids in COPD: improving efficacy

IA Yang, JG Shaw, JR Goddard… - Expert review of …, 2016 - Taylor & Francis
Chronic obstructive pulmonary disease (COPD) is a chronic, inflammatory lung disease
characterized by airflow limitation that is not fully reversible. The pathological changes in …

Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD

D Price, B Yawn, G Brusselle, A Rossi - Primary Care Respiratory …, 2013 - nature.com
While the pharmacological management of chronic obstructive pulmonary disease (COPD)
has evolved from the drugs used to treat asthma, the treatment models are different and the …